Skip to content

2012 Press Releases

Dec 19, 2012

Allergan, Inc. Announces Completion of SkinMedica, Inc. Acquisition  

Dec 19, 2012

Allergan's BOTOX® (botulinum toxin type A) Receives a Positive Opinion in Fourteen European Countries for Idiopathic Overactive Bladder  

Nov 16, 2012

Allergan, Inc. to Acquire SkinMedica, Inc.  

Oct 30, 2012

Allergan Reports Third Quarter 2012 Operating Results  

Oct 3, 2012

Allergan Announces Quarterly Conference Call  

Oct 1, 2012

Allergan Comments on Order Regarding Permanent Injunction against Merz Pharmaceuticals and Merz Aesthetics  

Sep 27, 2012

Allergan's BOTOX® (Botulinum Toxin Type A) Receives UK Authorisation for Urinary Leakage in Patients with Multiple Sclerosis or Spinal Cord Injury  

Sep 4, 2012

Allergan Opens New Research and Development Center in Bridgewater, New Jersey  

Aug 21, 2012

Allergan and Molecular Partners Enter into Exclusive Alliance  

Aug 1, 2012

Allergan Reports Second Quarter 2012 Operating Results  

Jul 6, 2012

Allergan Announces Quarterly Conference Call  

Jun 26, 2012

BOTOX® (Allergan's botulinum toxin type A) given Final Guidance from the National Institute for Health and Clinical Excellence (NICE) for the prevention of chronic migraine in patients who have failed previous treatme  

Jun 11, 2012

Scottish Medicines Consortium accepts OZURDEX® (dexamethasone 700mcg intravitreal implant) for use within NHS Scotland  

May 11, 2012

BOTOX Allergan's botulinum toxin type A recommended  

May 8, 2012

Allergan Launches First EU Public Awareness & Education Campaign on the Importance of Quality in Medical Aesthetics  

May 2, 2012

Allergan Reports First Quarter 2012 Operating Results  

Apr 13, 2012

BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval  

Apr 6, 2012

Allergan Announces Quarterly Conference Call  

Mar 28, 2012

Allergan Announces Positive Top-Line Results from Phase III BOTOX® Overactive Bladder Program  

Mar 12, 2012

U.S. Federal Court Finds in Favor of Allergan, Inc. and Issues Permanent Injunction against Merz Pharmaceuticals and Merz Aesthetics  

Showing 1-20 of 23
Page: 1 2
 Next 20